Jacinthe HamiltonJacinthe Hamilton
|
 |
The aim of this pilot study was to genital herpes evaluate the safety and efficacy of lowering immunosuppression in kidney transplant recipients who exhibit mildly symptomatic CMV infections while on valAcyclovir / Aciclovir prophylaxis. We selected 12 patients who experienced mildly symptomatic CMV infections defined as a positive genital herpes CMV-pp65 antigenaemia test associated with either neutropenia, asthenia or arthralgia, but no fever. Women significantly emergency contraception cvs presented more often with extragenital infections online pharmacies of HSV-2 [36/59 (61%)] than men [18/111 (16%)]. The mildly symptomatic infections occurred at a median interval of 69 days after transplantation-during prophylaxis in eight cases and after valAcyclovir / Aciclovir ear infection antibiotics adults discontinuation antibiotic in the other four cases. All of them were effectively managed by lowering immunosuppressive therapy, leading to the disappearance of symptoms antibiotics and CMV antigenaemia reduction. Testing for CMV-pp65 antigenaemia was performed weekly for 6 months. The underdiagnosis of genital herpes simplex seems largely due to misinterpretation of atypical genital and extragenital lesions. More than half of the patients with genital herpes simplex of a mainly immunocompetent population presented with atypical manifestations. Ganciclovir never became necessary. Most data of genital herpes simplex have been collected in STD clinics in the USA where unrecognized forms accounted for 80% of HSV-2 infections. The heterogeneous valacyclovir clinical spectrum of Genital Herpes.BACKGROUND AND OBJECTIVE. A pilot study.BACKGROUND. No immunological complication or recurrence of CMV infection or disease was noted. 111 (65%) men and 59 (35%) women were identified with a mean age of 44 years. All of them received prophylaxis with valAcyclovir / Aciclovir for at least 3 months. Our aim was to study the clinical features in an outpatient clinic of dermatology. Routine cytomegalovirus (CMV)-pp65 antigenaemia monitoring shows that some patients will develop pp65 antigenaemia during valAcyclovir / Aciclovir prophylaxis or after cessation of treatment. The mildly symptomatic CMV infections occurring in valAcyclovir / Aciclovir-treated patients may be managed efficiently and without immunologic complication by lowering immunosuppressive therapy.. The charts of 170 patients, previously monitored prospectively for a HIV prevalence study, with culture-confirmed genital herpes simplex or herpetic infection with HSV-2 at any other site presenting between 1995 and 1999 were analyzed. Only 49% had a typical cluster of genital lesions. Karger AG, Basel Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valAcyclovir / Aciclovir prophylaxis. Eighty-six (51%) presented with either lesions at extragenital sites [mostly the buttocks 33/170 (19%), thigh 10/170 (6%), anal region 9/170 (5%) and fingers 8/170 (5%)] or sho morphologically atypical forms of isolated genital lesions [single ulcer 16/170 (9%), erosion 6/170 (4%), crust 3/170 (2%) and fissure, edema or erythema each 1/170 (1%)].
|